382.29999 EUR
3.9
1.03%
Last update Dec 12, 11:13 AM CET
Main market
Day range
379.60001
382.29999
Previous close
378.39999
Open
379.60001
Access this stock data via API
Subscribe
Vertex Pharmaceuticals Inc.
382.30
3.90
1.03%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 2.6B 2.5B 2.4B 2.5B
Cost of revenue 353.3M 347.1M 309.2M 360.6M
Gross profit 2.3B 2.2B 2.1B 2.1B
Operating expense
Research & development 832.8M 833.4M 834.5M 4.8B
Selling general and admin 379.1M 361.7M 337.6M 321.6M
Other operating expenses
Operating income 1.1B 983.1M 878.2M -3.0B
Non operating interest income
Income 107.1M 104.3M 103.0M 109.2M
Expense 2.8M 3.2M 2.6M 2.4M
Other income expense -53.1M 8.6M -356.5M 3.9B
Pretax income 1.1B 1.1B 622.1M 968.0M
Tax provision 183.9M 213.0M 71.6M 190.4M
Net income 922.4M 879.8M 550.5M 777.7M
Basic EPS 4.0 2.5 3.6
Diluted EPS 4.0 2.5 3.5
Basic average shares 218.6M 218.8M 219.3M
Diluted average shares 220.5M 221.0M 221.9M
EBITDA 1.2B 1.1B 1.0B -2.9B
Net income from continuing op. 922.4M 879.8M 550.5M 777.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours

12:59
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).